Safe Coronavirus Vaccine Could Take 12-18 Months, Says GSK's Breuer

The video discusses the typical timeline for vaccine development, which usually takes 8 to 10 years, but new technologies could reduce this to 12 to 18 months. It highlights the current status of the COVID-19 outbreak, with exponential cases in China and sporadic cases in Europe and the US. Gilead is conducting human trials in China with existing drugs, which are already known for their safety. GSK is making its platform available to external researchers to aid in vaccine development.

How does the current outbreak situation affect vaccine development strategies?

What role does GSK play in the current vaccine development efforts?